If a reasonable possibility exists that a non-penicillin drug product has been exposed to cross-contamination with penicillin, the non-penicillin drug product shall be tested for presence of penicillin.
The graph holds this control, the 0 it maps to, and the evidence behind each claim, over MCP and REST.